Also from Division of Manufacturing and Product Quality,
Office of Compliance says that:
“US FDA could potentially require drug makers to conduct on-
site audits at manufacturing facilities run by outside
contractors.”
Director of US FDA, DMPQ (Division of Manufacturing & Product Quality) says:
“This technology does sound like it has some promise to help a firm’s external
auditors with additional expertise in some cases without being at the audited site”